 comparison propranolol diltiazem nifedipin treatment ambulatori ischemia patient stabl angina differenti effect ambulatori ischemia exercis perform angin symptom asi studi group episod transient myocardi ischemia ambulatori activ common patient stabl coronari arteri diseas asymptomat select therapi episod asymptomat ischemia lack direct compar studi effect monotherapi patient stabl angina high frequenc asymptomat ischem episod propranolol-la mean mg diltiazem-sr mean mg nifedipin mean mg placebo week random double-blind crossov trial entri criteria posit exercis treadmil test placebo therapi mm ST segment depress angina pectori episod transient ST segment depress mm ambulatori electrocardiogram ninety-four patient elig random therapi patient treatment period intent-to-treat analysi fifti patient treatment phase protocol-complet analysi anti-ischemia efficaci ambulatori electrocardiograph monitor exercis treadmil test angin diari ninety-four percent episod ambulatori ischemia asymptomat placebo propranolol mark reduct manifest asymptomat ischemia ambulatori electrocardiograph monitor versu hr mean durat ischemia hour versu minut diltiazem reduct frequenc episod placebo versu hr trend protocol-complet analysi signific reduct intent-to-treat analysi nifedipin signific effect measur variabl ambulatori ischemia dosag medic excess patient benefici effect evid dose contrast mark effect activ agent ambulatori asymptomat ischemia effect exercis perform angina pectori slight activ agent treadmil exercis durat time mm ST segment depress propranolol diltiazem signific effect total exercis time angin frequenc propranolol diltiazem abstract truncat AT word